Brief: Algernon Pharmaceuticals Announces Private Placement
13/02/2020 14:19
Feb 13 (Reuters) - Algernon Pharmaceuticals Inc AGN.CD :
* ALGERNON PHARMACEUTICALS ANNOUNCES PRIVATE PLACEMENT
* ALGERNON PHARMACEUTICALS INC - UNDERTAKING A NON-BROKERED
PRIVATE PLACEMENT OF UP TO 14.1M UNITS AT A PRICE OF $0.085 PER
UNIT
* ALGERNON PHARMACEUTICALS - NET PROCEEDS OF OFFERING WILL
BE USED
TO FUND PLANNED PHASE CLINICAL TRIAL FOR IDIOPATHIC PULMONARY
FIBROSIS
Source text for Eikon: ID:nGNX5YWF6z
Further company coverage: AGN.CD
(Reuters.Briefs@thomsonreuters.com)
Recent news on Grey Matters Health
See all newsBrief: Grey Matters Announces The Closing Of Its Equity And Convertible Debenture Private Placement Totalling CAD $1.12 Million
Brief: Algernon Announces Additional Increase To Private Placement Financing
Brief: Algernon Health Announces Private Placement
Brief: Algernon Announces Closing Of The Private Placement Financing
Brief: Algernon Announces $1 Mln Private Placement